SAMD9 is an innate antiviral host factor with stress response properties that can be antagonized by poxviruses

Journal of Virology

Volumn 89, Issue 3, 2015, Pages 1925-1931

  Liu, Jia ^a   McFadden, Grant ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; INITIATION FACTOR 2ALPHA; PROTEIN SAMD9; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; PROTEIN; SAMD9 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL GRANULE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; INNATE IMMUNITY; NONHUMAN; POXVIRIDAE; POXVIRUS INFECTION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; HELA CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM;

EUKARYOTA; MYXOMA VIRUS; VACCINIA VIRUS;

ANTIVIRAL AGENTS; HELA CELLS; HUMANS; IMMUNITY, INNATE; POXVIRIDAE; PROTEINS;

EID: 84921481485     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02262-14     Document Type: Article

References (17)

1. Liu J, Wennier S, Zhang L, McFadden G. 2011. M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells. J Virol 85:3270-3282. http://dx.doi.org/10.1128/JVI.02243-10.
2. Simpson-Holley M, Kedersha N, Dower K, Rubins KH, Anderson P, Hensley LE, Connor JH. 2011. Formation of antiviral cytoplasmic granules during orthopoxvirus infection. J Virol 85:1581-1593. http://dx.doi.org/10.1128/JVI.02247-10.
3. Tourrière H, Chebli K, Zekri L, Courselaud B, Blanchard JM, Bertrand E, Tazi J. 2003. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol 160:823-831. http://dx.doi.org/10.1083/jcb.200212128.
4. Kedersha NL, Gupta M, Li W, Miller I, Anderson P. 1999. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol 147:1431-1442. http://dx.doi.org/10.1083/jcb.147.7.1431.
5. Wehner KA, Schutz S, Sarnow P. 2010. OGFOD1, a novel modulator of eukaryotic translation initiation factor 2alpha phosphorylation and the cellular response to stress. Mol Cell Biol 30:2006-2016. http://dx.doi.org/10.1128/MCB.01350-09.
6. Kedersha N, Chen S, Gilks N, Li W, Miller IJ, Stahl J, Anderson P. 2002. Evidence that ternary complex (eIF2-GTP-tRNA(i) (Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol Biol Cell 13:195-210. http://dx.doi.org/10.1091/mbc.01-05-0221.
7. Liu J, Rothenburg S, McFadden G. 2012. The poxvirus C7L host range factor superfamily. Curr Opin Virol 2:764-772. http://dx.doi.org/10.1016/j.coviro.2012.09.012.
8. Meng X, Chao J, Xiang Y. 2008. Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L. Virology 372:372-383. http://dx.doi.org/10.1016/j.virol.2007.10.023.
9. Bartee E, Mohamed MR, Lopez MC, Baker HV, McFadden G. 2009. The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts. J Virol 83:498-511. http://dx.doi.org/10.1128/JVI.01376-08.
10. Meng X, Jiang C, Arsenio J, Dick K, Cao J, Xiang Y. 2009. Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons. J Virol 83:10627-10636. http://dx.doi.org/10.1128/JVI.01260-09.
11. Villa NY, Bartee E, Mohamed MR, Rahman MM, Barrett JW, Mc-Fadden G. 2010. Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells. Virology 401:266-279. http://dx.doi.org/10.1016/j.virol.2010.02.027.
12. Kuznetsov G, Xu Q, Rudolph-Owen L, Tendyke K, Liu J, Towle M, Zhao N, Marsh J, Agoulnik S, Twine N, Parent L, Chen Z, Shie JL, Jiang Y, Zhang H, Du H, Boivin R, Wang Y, Romo D, Littlefield BA. 2009. Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Mol Cancer Ther 8:1250-1260. http://dx.doi.org/10.1158/1535-7163.MCT-08-1026.
13. Low WK, Li J, Zhu M, Kommaraju SS, Shah-Mittal J, Hull K, Liu JO, Romo D. 2014. Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents. Bioorg Med Chem 22:116-125. http://dx.doi.org/10.1016/j.bmc.2013.11.046.
14. Backes S, Sperling KM, Zwilling J, Gasteiger G, Ludwig H, Kremmer E, Schwantes A, Staib C, Sutter G. 2010. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha. J Gen Virol 91:470-482. http://dx.doi.org/10.1099/vir.0.015347-0.
15. Ramsey-Ewing AL, Moss B. 1996. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene. Virology 222:75-86. http://dx.doi.org/10.1006/viro.1996.0399.
16. Langland JO, Jacobs BL. 2004. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 324:419-429. http://dx.doi.org/10.1016/j.virol.2004.03.012.
17. Zhang P, Jacobs BL, Samuel CE. 2008. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis. J Virol 82:840-848. http://dx.doi.org/10.1128/JVI.01891-07.